Multimodal integration of homotopic connectivity and transcriptomic signatures in major depressive disorder with sleep disorder comorbidity

重度抑郁症合并睡眠障碍中同源连接和转录组特征的多模态整合

阅读:1

Abstract

BACKGROUND: Major depressive disorder (MDD) affects over 300 million people globally, with sleep disorder (SD) being a common symptom. However, the neural mechanisms underlying this comorbidity remain poorly understood. Specifically, the role of interhemispheric functional connectivity, measured via voxel-mirrored homotopic connectivity (VMHC), in MDD with or without SD has not been systematically explored. This study aimed to identify distinct VMHC patterns in MDD patients with SD and without SD and investigate their genetic correlates. METHODS: Resting-state functional magnetic resonance imaging (fMRI) was performed in 26 MDD patients with SD (Pa_s), 34 without SD (Pa_ns), and 34 healthy controls (HCs). VMHC analysis compared interhemispheric connectivity across groups, followed by receiver operating characteristic (ROC) analysis to evaluate diagnostic utility. Genetic neuroimaging correlation analysis integrated transcriptomic data from the Allen Human Brain Atlas to identify genes and pathways associated with VMHC alterations. RESULTS: Compared to Pa_ns, Pa_s exhibited increased VMHC in the precuneus and postcentral gyrus. Relative to healthy controls, both MDD subgroups showed widespread network dysfunction. ROC analyses confirmed that VMHC in the precuneus and postcentral gyrus effectively distinguished MDD patients with and without SD, indicating diagnostic potential. Additionally, we identified genes related to Pa_s-Pa_ns differences in VMHC values and the associated biological processes and signaling pathways. CONCLUSIONS: This study reveals distinct VMHC signatures in MDD-SD, emphasizing the critical roles of the default mode and sensorimotor networks in sleep-depression comorbidity. The robust diagnostic performance of precuneus and postcentral gyrus VMHC supports their use as biomarkers for subtype differentiation. Identified genetic pathways offer novel targets for mechanistically informed therapies, advancing personalized interventions for MDD-SD. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。